Clearance Summary
LDH/NADH,LDH/NADH, NAD & NAD DIAPHORASE received FDA 510(k) clearance under submission number K770401, sponsored by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1977-04-26.
- Submission: K770401
- Applicant / Sponsor: Bd Becton Dickinson Vacutainer Systems Preanalytic
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.2500
- Decision date: 1977-04-26
Classification & Regulation
This clearance is catalogued under FDA product code JJI and 21 CFR 862.2500, within the Clinical Chemistry review panel as a Class I device.